Sue Lee, MD
Gastroenterology · Hermitage, TNNPI 1720086317
Payments from drug & device makers
Across 211 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AbbVie$803
- Amgen$459
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$445
- Pfizer$400
- Johnson & Johnson$350
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$1,25022%
- Food & beverage$4,46177%
- Education$160%
- Other$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 4 | $1,296 |
| AbbVie | 51 | $803 |
| Amgen | 5 | $459 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $445 |
| Pfizer | 11 | $400 |
| Johnson & Johnson | 24 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $305 |
| Regeneron Healthcare Solutions, Inc. | 9 | $272 |
| Bristol Myers Squibb | 11 | $210 |
| QOL Medical, LLC | 12 | $202 |
| Medtronic | 2 | $156 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| Braintree Laboratories, Inc. | 6 | $96 |
| Ironwood Pharmaceuticals, Inc | 5 | $80 |
| Ardelyx, Inc. | 5 | $78 |
| Merck | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Nestle Healthcare Nutrition Inc. | 3 | $47 |
| Organon | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $40 |
| Sanofi | 2 | $35 |
| Baxter Healthcare | 1 | $34 |
| AstraZeneca | 1 | $25 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Shionogi Inc | 1 | $23 |
| Evoke Pharma, Inc. | 1 | $21 |
| MDD US Operations, LLC | 1 | $20 |
| Gilead | 1 | $20 |
| Celltrion USA Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,761 in reported general payments places this provider in the 60th percentile of 336 gastroenterology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 90 | $5,460 |
| Balsalazide Disodium | 30 | $2,990 |
| Dicyclomine Hcl | 16 | $1,125 |
| Esomeprazole Magnesium | 40 | $1,009 |
| Sulfasalazine | 11 | $605 |
| Omeprazole | 27 | $495 |
| Pantoprazole Sodium | 30 | $486 |
| Lansoprazole | 17 | $302 |
| Famotidine | 32 | $220 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Hermitage
- Kevin FinneganHermitage$1.4M
- Jocelyne MillerHermitage$587K
- Sushil PatilHermitage$434K
- George JamesHermitage$156K
- Ziad YounesGermantown$15.6M
- Robert HerringNashville$3.2M
- Dawn Borromeo BeaulieuNashville$2.1M
- David SchwartzNashville$1.4M
- Baldeep PablaNashville$1.2M
- Sara HorstNashville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.